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I. INTRODUCTION 
Cancer known medically as a malignant neoplasm, is a broad group of various 
diseases, all involving unregulated cell growth. In cancer, cells divide and grow 
uncontrollably, forming malignant tumors, and invade nearby parts of the body. The 
cancer may also spread to more distant parts of the body through the lymphatic 
system or bloodstream. Not all tumors are cancerous. Benign tumors do not grow 
uncontrollably, do not invade neighboring tissues, and do not spread throughout the 
body. There are over 200 different known cancers that afflict humans. Most of all 
patients with terminal or advanced cancer suffer with poor mental health. Specifically, 
depression, anxiety, and adjustment disorders plague people with advanced or 
terminal cancer. 
Women’s health in recent years is more prone to cancer. It is being witnessed 
that urban population is developing breast cancer more than its rural counterpart. 
Lifestyle including food, mental health and hormonal imbalance has to be corrected to 
avoid such risks. Marriage at the right age and timely pregnancies also minimize risk 
of developing the disease.Cancer is curable if detected early and in terminal stages; it 
is the quality and not the quantity of life that really matters. Urban Indian women 
have fewer children and breastfeed them less than their rural counterparts, all of 
which increases their exposure to oestrogen. 
Radical mastectomy is a surgical procedure in which the breast, underlying 
chest muscles including pectorals major, minor muscle and lymph nodes are removed 
as a treatment of breast cancer. It was developed by William Stewart Halted in 1882. 
Women being treated for breast cancer in US, Underwent radical mastectomy this is a 
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morbid surgery and is not performed in extreme cases. There are three categories of 
Mastectomy. 
• Total Mastectomy 
• Radical Mastectomy 
• Partial Mastectomy 
Total mastectomy is the procedure in which the entire breast tissue is 
removed, but axillary contents are undisturbed. Sometimes the "sentinel lymph node" 
that is, the first axillary lymph node that the metastasizing cancer cells would be 
expected to drain into is removed. This surgery is sometimes done bilaterally (on both 
breasts) on patients who wish to undergo mastectomy as a cancer-preventative 
measure. Patients who undergo simple mastectomy can usually leave the hospital after 
a brief stay. Frequently, a drainage tube is inserted during surgery in their chest and 
attached to a small suction device to remove subcutaneous fluid. These are usually 
removed several days after surgery as drainage decrease to less than 20-30 ml per day. 
In modified radical mastectomy entire breast tissue is removed along with the 
axillary contents (fatty tissue and lymph nodes). In contrast to a radical mastectomy, 
the pectoral muscles are spared. 
Radical mastectomy is the procedure involves removing the entire breast, the 
axillary lymph nodes, and the pectoralis major and minor muscles behind the breast. 
This procedure is more disfiguring than a modified radical mastectomy and provides 
no survival benefit for most tumors. This operation is now reserved for tumors 
involving the pectoralis major muscle or recurrent breast cancer involving the chest 
wall. Lymphedema is a major complication which arises due to post radical 
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mastectomy. Lymphedema develops after breast surgery because there is an alteration 
in the pathway that drains the fluid involved in the immune system. It can occur at 
any time after the surgery if untreated, it can become worse. 
Lymphedema is an abnormal build up of fluid that causes swelling most often 
in the arms or leg. The condition develops when lymph vessels or lymph nodes are 
missing, impaired, damaged or removed. There are two types of lymphedema. 
• Primary Lymphedema  
• Secondary Lymphedema 
Primary Lymphedema is rare and is caused by the absence of / or 
abnormalities in certain lymph vessels at birth. 
Secondary Lymphedema occurs as a result of a blockage or interruption that 
alters the flow of lymph through the lymphatic system and can develop from an 
infection cancer, surgery, scar tissue formation trauma, DVT, radiation or other 
cancer treatment. The standard physiotherapy management for secondary 
lymphedema are lymphatic manipulation, intermittent pneumatic compression pump 
and decongestive therapy. 
Lymphatic manipulation was developed by Danish Physical therapist Dr. Emil 
and Estrid Vodder, in the 1930. This technique developed as a result of their studies 
on the lymph vessel system.  Lymphatic manipulation is a series of light rhythmic 
manipulation that stimulates Lymph flow. This rhythmical massage stimulates the 
lymphatic vessels. 
4 
 
The lymphatic vessels in our body play a key role in delivering nutrients and 
anti bodies, and other immune constituents to the tissue cells of the body and remove 
toxin, cell waste and their particles when the lymphatic vessel are not functioning 
properly due to blockages the body immunity drop and it is susceptible to the number 
of ailments such as infection, malignancy. 
 Lymphatic manipulation helps in removing these blockages and restores the 
lymphatic system to its normal stage. It also works on nervous system, lower blood 
pressure, reduces Stress and improves sleeping pattern. Lymphatic manipulation is 
both a preventive and a remedial treatment. It provides a major boost to the immune 
system. It has been proven to be very effective in the treatment of condition such as 
malignancy. 
Intermittent pneumatic compression pump were at one time a standard 
treatment for lymphedema. These older types referred to as pneumatic compression 
device consist of an inflatable garment for the arm, leg or foot and an electrical 
pneumatic pump that fills the garment with compressed air, the garment is 
intermittently inflated and deflated with cycle times and pressures that vary between 
devices. Today there is a new generation pumps that act frequently with less pressure 
being applied.  
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1.2.NEED OF THE STUDY 
There are many treatment to reduce lymphedema among subjects of post 
radical mastectomy, need of the study was to compare Lymphatic Manipulation is 
more effective or intermittent pneumatic compression pump is more effective to 
reduce lymphedema and its related functional limitations. 
 
1.3. OBJECTIVE OF THE STUDY 
• To evaluate the outcome of lymphatic manipulation as a component of 
physical therapy treatment for lymphedema compared to intermittent 
pneumatic compression pump. 
• To determine whether the lymphatic manipulation or intermittent pneumatic 
compression pump removes Lymphedema and promotes recovery and 
improvement of functional activities among individual with secondary 
Lymphedema. 
 
1.4.STATEMENT OF THE PROBLEM 
The study was to compare Lymphatic Manipulation and Intermittent 
pneumatic compression pump to reduce lymphedema and its related functional 
limitation in post radical mastectomy. 
 
1.4. HYPOTHESIS 
1.4.1. Null Hypothesis 
• There is no significant difference in lymphedema and its functional limitation 
following lymphatic manipulation and intermittent pneumatic compression 
pump post radical mastectomy subjects.  
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• There is no significant difference between lymphatic manipulation and 
intermittent pneumatic compression pump on reducing lymphedema and its 
related functional limitation among post radical mastectomy subjects.  
 
1.4.2. Alternate Hypothesis 
• There is significant difference in lymphedema and its functional limitation 
following lymphatic manipulation and intermittent pneumatic compression 
pump post radical mastectomy subjects.  
• There is significant difference between lymphatic manipulation and 
intermittent pneumatic compression pump on reducing lymphedema and its 
related functional limitation among post radical mastectomy subjects.  
 
1.5. OPERATIONAL DEFINITIONS 
Lymphatic Manipulation 
Lymphatic manipulation is a series of light rhythmic manipulation that 
stimulates Lymph flow. Manual lymph drainage is a gentle manual treatment 
technique based on four basic strokes.  
Intermittent Pneumatic compression Pump 
Intermittent pneumatic compression is a therapeutic technique used in medical 
devices that include an air pump and inflatable axillary sleeves, gloves or boots in a 
system designed to improve venous circulation in the limbs of patients who suffer 
edema. 
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Lymphedema 
Lymphedema is an abnormal build up of fluid that causes swelling most often 
in the arms or leg. The condition develops when lymph vessels or lymph nodes are 
missing, impaired, damaged or removed. 
Functional limitation 
The limitation to perform a movement concerning daily living activities.  
Radical Mastectomy 
Radical mastectomy is a surgical procedure in which the breast, underlying 
chest muscles including pectorals major, minor muscle and lymph nodes are removed 
as a treatment of breast cancer. 
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II. REVIEW OF RELATED LITERATURE 
 
SECTIONS 
Section A : Studies on the Effect of lymphatic manipulation among 
lymphedema subjects. 
 
Section B : Studies on the Effect of pneumatic compression pump 
among lymphedema subjects. 
 
Section C : Incidence of lymphedema among post radical mastectomy 
subjects. 
 
           Section D : Studies on reliability and validity of Tonometer. 
 
Section E : Studies on reliability and validity of lymphedema    
Functioning, Disability and Health Questionnaire. 
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Section A 
Studies on the Effect of lymphatic manipulation among lymphedema subjects. 
Henaeres.(1998) concluded, that an early physiotherapy group was treated by a 
physiotherapist with physiotherapy program including lymphatic manipulation. The 
controlled group received educational strategy alone, 116 women completed the one 
year follow up. Of these 18 developed secondary lymphedema, 14 in the control 
group and 4 in the intervention group. The difference was significant. Risk ratio 0:28, 
a survival analysis showed a significant difference. With secondary lymphedema 
being diagnosed four times earlier in the control group. These studies were made on 
lymphatic manipulation could be effective intervention in the prevention of secondary 
lymphedema in women for at least one year after surgery. For breast cancer 
involvingdissection of axillary lymph nodes. 
Oxford Journals; annuals of oncology, Issue 4;PG 639-646, (2006.) the systematic 
review undertook a broad investigation of commonly investigated conservative 
therapies, including lymphatic manipulation, pneumatic pumps, limb elevation. All 
conservative therapies produced improvement in subjects arm. In symptoms quality of 
life where identified. Benefits in lymphatic manipulation improved functional 
limitation. 
Khalil and Baker. (2007) concluded, the early physiotherapy could be an effective 
intervention in the prevention of secondary lymphedema in women for at least one 
year after surgery for breast cancer involving dissection of axillary lymph node.120 
women who had breast surgery involving dissection of axillary lymph nodes were 
randomly assigned to a treatment group. Physiotherapist put the patient through a 
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program included lymphatic manipulation, Active and active assisted shoulder 
exercises. This group also received educational strategy. In controlled group 
educational strategy alone the incidence of clinical significant lymphedema reduction 
was noted. 
Martin M.L et al.(2011) concluded, from a randomized controlled trial in 58 women 
post mastectomy lymphedema. The control group includes 29 patients with standard 
treatment pneumatic compression; the experimental group includes 29 patients with 
lymphatic manipulation. The therapy will be administrated daily for four weeks and 
the patient condition will be assessed. The primary outcome parameter, Is volume 
reduction of affected arm. The result of the study will provide information on the 
effectiveness of lymphatic manipulation and its impact on the quality of life and 
physical limitation of this patient. 
Dr. Emil and Vodder (1936) concluded lymphatic manipulation is a form of 
manipulation that stimulates the lymphatic system with gentle strokes. The light 
strokes encourage the lymphatic system to eliminate metabolic waste product, excess 
fluid, and bacteria. The technique was invented by them. 
David Goddard. (1998) concluded that the immune system protects the body against 
infection. It transports the nutrients to cells and eliminates metabolic wastes, toxins 
and excess fluids from the body. Lymphatic manipulation is also a very effective way 
of detoxing the body plus stimulating vital immune deficiency. 
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Section B 
Studies on the Effect of pneumatic compression pump among lymphedema 
subjects. 
Richmond and Donell, Archives of surgery (1985) concluded, prospectively the 
effect of a new compression device for lymphedema which utilizes, a short duration 
and high pressure cycle that provide a sequential milking pattern to the limb through 
multiple compartmental. Twenty five patients underwent 20 minute treatment at upper 
extremities showed a decrease in circumference measurement with the maximal 
reduction in occurring a wrist. Despite the high pressure no serum muscle enzymes 
level was noted this device reduce lymphedema in limbs. 
Dini and Gozza,( Annuals of 1998) concluded, pneumatic compression is a 
frequently prescribed physical therapy for patient affected by post mastectomy 
lymphedema. But despite its wide use its efficacy has been demonstrated in phase 
three studies, they performed a randomized study comparing pneumatic compression 
versus no treatment in patients with post mastectomy lymphedema. Lymphedema was 
assessed by the sum of difference in circumference measurement between affected 
and normal limb, response was deducted by a 25 percent reduction in delta value. 
Tiwari (2003 FEB) stated that treatment of arm lymphedema is much the same 
treatment for leg lymphedema, the preferred treatment is pneumatic compression. 
However the arm lymphedema has been shown that a treatment protocol including 
sequential pump therapy with manual decongestive therapy has obtained the best 
result. 
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Moosea.Y et al.; (April 2010) focused on lymphedema resulting from breast cancer 
surgery. Their finished review concluded that compression bandages decreases 
lymphedema. Pneumatic pump and lymphatic manipulation have more volume 
reduction of lymphedema, intermittent pneumatic compression pump provide similar 
benefits of soothing effect and improves functional limitation. Comparatively they are 
less time consuming by which more then one patient can be treated at a time. 
Megens and Haris.(2004) concluded, that in management of lymphedema following 
treatment of breast cancer. Thirteen subjects met the criteria for experimental 
research, which were categorized according to scatters level of evidence, one study 
was graded at level five, the other at level 6, from the level of evidence and scientific 
rigor pneumatic compression is proved effective. 
Section C 
Incidence of Lymphedema among post radical mastectomy subjects. 
M.J. Brennan. et al. (FEB 1998) concluded that lymphedema  is a relatively frequent 
complication following the management of  breast carcinoma, numerous therapy 
intervention have been offered to treat this potentially disabling and disfiguring 
condition consensus have not been attained among oncologist surgeon, psychiatrist 
concerning the appropriate treatment of lymphedema. A review of available literature 
suggest that a variety of traditional and commonly available technique when used 
appropriately in a multi diplomacy fashion, may lessen the condition and impairment 
associated with acquired lymphedema the role of surgery is unclear manual 
mechanical therapies are promising. 
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DINI et al. (2008) concluded, with secondary arm lymphedema is a chronic and 
distressing condition which affect a significant number breast cancer. A number of 
health professional investigated conservative therapies have been developed to help 
with this. 
Ribeirão Preto, Rev. Latino-Am. Enfermagem. (Sept./Oct. 2009)concluded that 
the Breast cancer is one of the most common types among women and can lead to 
high morbidity and mortality rates. Surgeries performed as part of breast cancer 
treatment include (radical and modified) mastectomies and conservative surgeries. 
Independently of what type of surgery is performed, these techniques can be 
accompanied by axillary lymph node drainage, which may cause upper limb 
lymphedema. As a part of treatment, physiotherapy plays a role in postoperative 
physical rehabilitation, preventing and treating complications like lymphedema, 
decrease movement range of upper limb joints, correcting postural malalignment and 
sensitive alterations and, thus, promoting functional recovery and a better quality of 
life. 
Yasir and Umer. (1998). concluded that lymphedema following radical mastectomy 
or axillary clearance and radiotherapy seems to be the main predisposing factor, 
lymphatic blockage resulting in stimuli for growth factors and cytokines with a 
consequent proliferation of vessels and lymphatic is one hypothesis that explains the 
proliferations of lymphatic vessels in the affected oedematous tissue. 
Nudelman (2000) concluded that lymphedema is a common complication of cancer 
treatment and has been identified as the number issue by breast cancer survivors with 
incidence as high as 70% given the long term survivors of these women, lymphedema 
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is a widely prevalent condition. Infra red radiation of axillary and supraclavicular 
lymph nodes increases a patient’s risk of lymphedema onset and progression by as 
much as two fold. 
Section D 
Studies on reliability and validity of Tonometer. 
Haris and Pillar (2009) concluded, superficial lymphatic system is divided in areas 
called the lymphatic territories which are separated by water sheds. When the 
lymphatic system fails to remove its load either due to surgery or mal formation, then 
the fluid accumulate in that territory, anatomic connection exists across the water 
sheds and while they work unaided lymphatic manipulation help the movement of 
fluid into lymph vessels. The purpose of the study is to examine the effectiveness of a 
manual technique, in moving fluid and softening them, and used three tools to 
examine the edema patient, were given 45 minute treatment in Vodder School and 
cross section of patient with secondary arm lymphedema. The tools used were 
tonometry, multiple frequency bio electrical impedance and aerometry. All three 
evolution tool indicated movement of fluid to different unblocked lymphatic 
territories softening of tissues in some of affected limb. Tonometry proved effective 
and more applicable. 
Deak et al. (2000) stated that Tonometer has been frequently used since its inspection 
as a mean to deduct fibrotic indurations in the tissues, resistance to compression, and 
the extent of fluid buildup. Or lymphedema. Tonometer has been frequently used, 
since its portable less expensive, safe, easily available and is reliable. 
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Golshanand Smith (2006) stated that the most common method lymphedema 
measurement is tonometry, most clinician does not take pre operative settings, 
tonometry is safe and reliable in such cases. The measurements are made with 
midpoint of arm and fore arm in upper limb. It relate the extent of fiber build up, and 
all Tonometer points were located using anatomical land mark for reproducibility. 
Section E 
Studies on reliability and validity of lymphedema A Functioning, Disability and 
Health Questionnaire. 
Nele Devoogdt et al. (American Physical therapist association journal 2011) 
questionnaire was introduced in American Physical therapy Association journal, 
Lymphedema occurs frequently after axillary dissection for breast cancer and causes 
significant physical and psychosocial problems. To plan the treatment for 
lymphedema and monitor the patient’s progress, arm swelling and arm function need 
to be assessed.  The Lymph-ICF is a descriptive and evaluative tool and consists of 29 
questions about impairments in function, activity limitations, and participation 
restrictions of patients with breast cancer and arm lymphedema. The questionnaire is 
divided into 5 domains: physical function, mental function, household activities, 
mobility activities, and life and social activities. Reliability and validity were 
examined on 60 patients with lymphedema and 30 patients without lymphedema. 
Ridner SH. Care Cancer. (2005) author concluded that Content validity of the final 
version of the Lymph-ICF was very good for patients with arm lymphedema 
following axillary dissection. activity limitations, and participation restrictions have to 
be quantified with the following scale: Score 0 is no problem, Score 1 is a small 
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problem, Score 2  is a moderate problem, Score 3 is a severe problem, and Score 4 is 
a very severe problem.  Because of the gradation of this scale, we chose a VAS as 
scoring system and preferred not to use a Likert scale, as others did. 
Barranger. E, et al. J Surg Oncol. (2005) concluded that patients who experienced 
scoring problems because their complaints were not always present or not present for 
a long time, the therapist had to emphasize that they had to score their average 
complaints during the previous 2 weeks, as mentioned in the introduction of the 
questionnaire. Furthermore, a pilot version of the Lymph-ICF was constructed based 
on information from the literature and from complaints of patients with arm 
lymphedema. Afterward, the patients gave their comments on the questionnaire, 
which led to the construction of the final version of the Lymph-ICF. 
 Armer and Stewart , Lymphat Res Biol.  (2005) tested the validity in 2 ways and 
gave good results in the patients with arm lymphedema. Each domain of the Lymph-
ICF (except the life and social activities domain) had the strongest correlation and 3 
of 5 domains had the weakest correlation with the expected domains of the SF-36, 
confirming good convergent and divergent validity, respectively. Other studies found 
comparable13 or slightly higher correlations12 between their questionnaire and a 
questionnaire already tested on reliability and validity.  
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III.  METHODOLOGY 
 
3.1 STUDY DESIGN: 
Pre and post test experimental design. 
 
3.2 SAMPLING DESIGN: 
Consecutive sampling. 
   
3.3 STUDY SETTING: 
Lakeshore hospital, Maradu, Ernamkulam. Subjects included for the study are 
divided in to two groups group A and group B. 
Group A Subjects received lymphatic manipulation. 
Group B Subjects received intermittent pneumatic compression pump. 
 
3.4 STUDY DURATION: 
The study was conducted for a period of 12 weeks, thrice a week. 
 
3.5 CRITERIA FOR SELECTION OF SUBJECTS: 
3.5.1 Inclusion Criteria 
• Women aged 40-45years treated for unilateral post radical mastectomy. 
• Patient with ipsilateral lymphedema with a limb volume difference of at least 
50 ml compared to lateral limb. 
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• Patients who have finished treatment with radio therapy, chemo therapy at 
least 6 months before study begins. 
3.5.2. Exclusion Criteria 
• Malignant lymphedema of acute appearance within one year of post 
intervention. 
• Patient with paralysis or previous vascular disorder in the affected arm. 
• Patient with major limitation of 30% or more in any of the arc of ipsilateral 
shoulder. 
• Patient with contraindication of lymphatic manipulation, heart failure, 
uncontrolled hyper tension, arm impairment and radiodermatis. 
• Patient who have undergone rehabilitation within three months prior to 
recruitment. 
 
3.6 VARIABLES: 
3.6.1. Dependent variables :  Lymphedema, functional limitation. 
3.6.2. Independent variables  :  Lymphatic manipulation, intermittent  
  pneumatic compression pump. 
3.7 ASSESSMENT TOOL: 
• Tonometer to measure lymphedema. 
• Lymphedema Functioning, Disability and Health Questionnaire to measure 
functional limitation. 
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3.8 PROCEDURE: 
Figure: 1 Flow Chart 
Pre test post test experimental design 
Consecutive sampling 
N=30 
  
Group A 
N=15 
Group B 
N=15 
Pre Test measurement Procedure 
Lymphedema with Tonometer and 
Lymphedema Functioning, Disability and 
Health Questionnaire. 
Treatment Procedure 
Lymphatic Manipulation 
Treatment Procedure 
Pneumatic Compression Pump 
Post Test measurement Procedure 
Lymphedema with Tonometer and 
Lymphedema Functioning, Disability and 
Health Questionnaire 
Statistical Analysis 
Paired‘t’ Test   and 
Unpaired’t’ Test 
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30 medically directed unilateral lymphedema post radical  mastectomy 
subjects from physiotherapy outpatient department aged between 40 and 55years who 
fulfilled inclusion and exclusion criteria were selected by consecutive sampling 
method and randomly assigned to two groups of 15 subjects each as Group A and 
Group B. Group A assigned for Lymphatic Manipulation and Group B intermittent 
pneumatic compression pump were measured by Tonometer and lymphedema 
Functioning, Disability and Health Questionnaire and recorded. 
 
3.9 MEASUREMENT PROCEDURE: 
3.9.1 Lymphedema by Tonometer   
• Tonometer is a mean to detect fibrotic indurations in the tissue resistance to 
compression. 
• Tonometer relate the extent of fiber build up, is measured by placing the 
weight based Tonometer over the midpoint of lymphatic territory or over 
water shed.  
• A measurement is taken of the depth the plunger penetrates after a period of 2 
second and recorded on a analogue scale.  
• All Tonometer points were located using anatomical land mark for 
reproducibility. 
 
21 
 
Arm patient  
• Fore arm 
• Upper arm 
• Anterior and 
•  posterior thorax 
All Tonometer measurements was taken with patient supine and tested with 
muscle relaxed. 
3.9.2 Functional Limitation by Lymphedema Functioning, Disability and 
Health Questionnaire 
 It is a questionnaire method consisting of five phases in 29 items Scores are 
dependent on the marks made by the subjects respectively in the 29 items. Before the 
subjects start the therapy the therapist explains the five phases and items included. If 
they feel the particular item is not applicable or not long term average value can be 
remarked or not applicable remark can be made. The five Phases are namely. 
• Physical Condition 
• Mental condition 
• Household activity 
• Mobility  
• Social activity 
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Initially the information on impairments in function, activity Limitations, and 
participation restrictions was collected in 30 patients with subjective or objective 
lymphedema post radical mastectomy. Subjects were receiving treatment for their arm 
lymphedema are recruited from Lakeshore hospital. 
3.10. TREATMENT PROCEDURE: 
3.10.1 LYMPHATIC MANIPULATION TECHNIQUES 
Lymphatic manipulation is a manual treatment based on four strokes these 
basic strokes known as Stationary circle, pump, rotary and scoop. Techniques are 
designed to manipulate lymph nodes and lymphatic vessels with the goal of increasing 
their activity and promote the flow of lymph.  
The treatment is given in alternative working days patient positioning is 
supine lying with pillows to be head, the therapist stand at the side of the patient to 
respective arm to be treated during treatment. Fifteen Subjects treated with lymphatic 
manipulation are assigned to group A. 
Correct pressure is to be applied, this is about 1-4 ounces. Direction of stroke 
is to push the lymph towards the correct nodes. Sequence is the order of the strokes to 
drain an area, start near the node to be drained and push the fluid back in the direction 
of the node. In this way we clear a path for the lymph to move, as well as create a 
suctioning effect that draws the lymph to the node. 
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Pump technique: The entire palm and the proximal (upper) phalanges are used 
to apply a circle-shaped pressure on the skin, operating within almost the full range of 
motion in the wrist. Pumps are primarily used to manipulate lymph vessels located in 
the extremities and can be applied with one hand or bimanually. 
Rotary technique: The entire surface of the hand and fingers are used in an 
elliptical movement during the working phase. Like the scoop technique, rotaries are 
applied dynamically, meaning the working hand moves over the surface of the treated 
body part in a continuous fashion. If applied bimanually, the techniques are 
alternating. 
Scoop technique: The palmer surface of the hand moves dynamically over the 
skin. The hand movement is facilitated by transitional movement in the wrist, 
combined with forearm pronation and supination. 
Each technique is given five minutes with a total section of fifteen minutes 
after each section post test value calculated using tonometer and recorded. The pre 
test value are calculated and recorded at the beginning of the session and post test 
value at the completion of the treatment respectively after twelve weeks. 
3.10.2  INTERMITTENT PNEUMATIC COMPRESSION PUMP 
This is a multi-compartmental pressure system specifically designed for the 
treatment of primary or secondary lymphedema patients. Lymphapress utilizes a 
short-duration, adjustable high pressure cycle providing a sequential milking pattern 
to the upper or lower limb through multiple compartments. Thus, fluid moves from 
the distal area and progresses proximally. The unique overlapping of the twelve air 
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compartments within the sleeve guarantees a calibrated gradient pressure and prevents 
any gaps between the functioning compartments. The 30 second inflation cycles are 
alternated with an intermission phase to allow free flow of arterial blood.  This 
provides a comfortable treatment and accounts for maximal patient compliance. 
Subject positioning is supine lying with proper pillows to the head and arms at resting 
position. Wrap the belt around the arm of the patient and inflate and deflate according 
to patients response and comfort. Each session is carried for 15 minutes and after 
completion of treatment remove the belt and post test values are calculated with 
tonometer and recorded.  
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b) Un paired ‘t’ test   
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Where, 
 S   = Standard deviation. 
݊ଵ  = Number of subjects in Group A. 
݊ଶ = Number of subjects in Group B.     
ݔҧଵ  = Mean of the difference in values between pre-test and post-test in Group-A. 
ݔҧଶ  = Mean of the difference in values between pre-test and post-test in Group-B. 
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4.2. Data Analysis of lymphedema in Group A 
Subjects in Group A were given lymphatic manipulation for 12 weeks. Pre 
test, Post test scores were recorded and statistically analyzed as follows. 
Table 1: Shows the mean, mean difference standard deviation paired‘t’ test value 
of lymphedema in  group A  subjects. 
Measurement Mean 
Mean 
Difference 
Standard 
Deviation 
Paired ‘t’ value 
Pre test 
Post test 
42.06 
39.06 
3 1.6 7.24 
 
The calculated paired’t’ value for lymphedema in Group A is 7.24. The‘t’ 
table value is 3.250 at 0.005 level of significance. Since the calculated‘t’ value is 
more than ‘t’ table value, there is significant difference in Pre and Post test scores of 
Group A. Thus there is significant reduction in lymphedema following lymphatic 
manipulation in post radical mastectomy subjects. 
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Figure: 2 Graphical representation of Pre test Mean, Post test Mean and Mean 
Difference score of lymphedema in Group A. 
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4.3. Data Analysis of Lymphedema in Group B 
Subjects in Group B were given Intermittent Pneumatic compression Pump for 
12 weeks. Pre test and Post test scores were recorded and statistically analyzed as 
follows. 
Table: 2 Shows the mean, mean difference standard deviation paired ‘t’ test 
value of lymphedema in  group B  subjects.  
Measurement Mean 
Mean 
Difference 
Standard 
Deviation 
Paired ‘t’ value 
Pre test 
Post test 
42.06 
41 
1.06 0.45 9.03 
 
The calculated paired ‘t’ value for lymphedema in Group B is 9.03. The ‘t’ 
table value is 3.250 at 0.005 level of significance. Since the calculated ‘t’ value is 
more than ‘t’ table value, there is significant difference in Pre and Post test scores of 
Group B. Thus there is significant reduction in pain following Intermittent Pneumatic 
compression Pumps among lymphedema following lymphatic manipulation in post 
radical mastectomy subjects. 
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Figure: 3 Graphical representation of Pre test Mean, Post test Mean and Mean 
Difference score of lymphedema in Group B. 
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4.4. Data Analysis of Lymphedema of Group A and Group B 
 Subjects in Group A and Group B were given lymphatic manipulation and 
intermittent pneumatic compression pump for 12 weeks thrice a week and Pre-test, 
Post-test scores were recorded and statistically analyzed as follows. 
Table: 3 The Mean, Mean Difference, Standard Deviation and Unpaired ‘t’ 
values of Lymphedema in Group A and Group. 
Serial No Groups Improvement Standard Deviation 
Unpaired ‘t’ 
test 
 
 
1. 
2. 
 
 
Group A 
Group B 
 
Mean Mean Difference
 
1.18 
 
4.49 
3.00 
1.06 
1.94 
 The calculated unpaired ‘t’ value for lymphedema of Group A with Group B is 
4.49. The Unpaired ‘t’ table value is 2.878 at 0.005 level of 0 Since the calculated 
unpaired ‘t’ value is more than ‘t’ table value, there is significant difference in 
lymphedema score of Group A with Group B. Thus there is significant difference 
between Group A and Group B in reducing lymphedema among post radical 
mastectomy subjects. 
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Figure: 4 Graphical representation of Mean and Mean difference of 
Lymphedema values of Group A and Group B. 
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4.5. Data Analysis of Functional Limitations in Group A 
 Subjects in Group A were given lymphatic manipulation for 12 week thrice in 
a week. Pre test, Post test scores were recorded and statistically analyzed as follows. 
Table 4: The mean, mean difference, standard deviation and paired ‘t’ value on 
Pre test, Post test  scores of Functional Limitations in Group A. 
Measurement Mean Mean Difference Standard Deviation Paired ‘t’ value 
Pre test 
Post test 
83.66 
65.13 
18.53 2.7 25.88 
 
The calculated Paired ‘t’ value for Functional Limitations in Group A is 25.8. 
The ‘t’ table value is 3.250 at 0.005 level of significance. Since the calculated paired 
‘t’ value is more than ‘t’ table value, there is significant difference in Pre and Post test 
scores of Group A. Thus there is significant improvement in Functional Limitations 
following lymphatic manipulation in post radical mastectomy subjects. 
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Figure: 5 Graphical representation of Pre test Mean, Post test Mean and Mean 
Difference score of Functional Limitations in Group A. 
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4.6. Data Analysis of Functional Limitations in Group B 
Subjects in Group B were given intermittent pneumatic compression pump for 
12 weeks thrice a week. Pre test and Post test scores were recorded and statistically 
analyzed as follows. 
Table: 5  The Mean, Mean Difference, Standard deviation and Paired ‘t’ value 
on Pre test, Post test scores of Functional Limitations in Group B. 
 
The calculated paired ‘t’ value for Functional Limitations in Group B is 7.87. 
The paired ‘t’ table value is 3.250 at 0.005 level of significance. Since the calculated 
paired ‘t’ value is more than ‘t’ table value, there is significant difference in Pre and 
Post test scores of Group B. Thus there is significant improvement in Functional 
Limitations following intermittent pneumatic compression pump post radical 
mastectomy subjects. 
 
Measurement 
 
Mean 
 
Mean Difference 
 
 
Standard Deviation 
 
 
Paired ‘t’ value 
 
 
Pretest 
 
Post test 
 
83.66 
 
78.26 
 
 
5.4 
 
 
 
1.24 
 
 
 
16.84 
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Figure: 6 Graphical representation of Pre test Mean, Post test Mean and Mean 
Difference score of Functional Limitations in Group B. 
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4.7. Data Analysis of Functional Limitations of Group A and Group B 
 Subjects in Group A and Group B were given lymphatic manipulation and 
intermittent pneumatic compression pump for 12 weeks thrice a week and Pre-test, 
Post-test scores were recorded and statistically analyzed as follows. 
Table: 6 The Mean, Mean Difference, Standard Deviation and Unpaired ‘t’ 
values of Functional Limitations in Group A and Group B. 
Serial No Groups Improvement Standard Deviation Unpaired ‘t’ test 
 
 
 
1. 
 
 
2. 
 
 
 
Group A 
 
 
Group B 
Mean Mean Difference 
 
 
 
 
2.15 
 
 
 
 
16.74 
18.53 
 
 
5.40 
13.13 
 
The calculated unpaired ‘t’ value for Functional Limitations of Group A with 
Group B is 6.331. The Unpaired ‘t’ table value is 2.878 at 0.005 level of significance. 
Since the calculated Unpaired ‘t’ value is more than  ‘t’ table value, there is 
significant difference in Functional Limitations score of Group A with  Group B. 
Thus there is significant difference between Group A and Group B in improving 
Functional Limitations among post radical mastectomy subjects. 
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Figure: 7 Graphical representation of Mean and Mean difference of Functional 
Limitations values of Group A and Group B. 
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4.8. Results 
The number of subjects for the study was 30 (N=30).The subjects were 
divided into two groups , Group ‘A’ and Group ‘B’, each group consisting of 15 
subjects. Total treatment program was for a period of 12 weeks at approximately 15 
minutes per session thrice a week. Before the treatment started Group A and Group B 
were involved for pre-test assessment by tonometry for lymphedema and lymphedema 
Functioning, Disability and Health Questionnaire for functional limitation. Post-test 
assessments were repeated after the treatment for both the Groups. Group A was 
treated with lymphatic manipulation and Group B was treated with intermittent 
pneumatic compression pump. 
The calculated paired‘t’ value for lymphedema in Group A is 7.24 and     
Group B is 9.03. The‘t’ table value is 3.250 at 0.005 level of significance. Since the 
calculated‘t’ value is more than ‘t’ table value, there is significant difference in Pre 
and Post test scores of lymphedema in Group A and Group B. Thus there is 
significant reduction in lymphedema following lymphatic manipulation and 
pneumatic compression pump among post radical mastectomy subjects. 
The calculated paired ‘t’ value for Functional limitation in Group A is 25.88 
and Group B is 16.84. The ‘t’ table value is 3.250 at 0.005 level of significance. Since 
the calculated ‘t’ value is more than ‘t’ table value, there is significant difference in 
Pre and Post test scores of Functional limitation in Group A and Group B. Thus there 
is significant improvement in Functional limitation following lymphatic manipulation 
and intermittent pneumatic compression pump among post radical mastectomy 
subjects. 
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The calculated unpaired ‘t’ value of lymphedema of Group A and Group B for 
lymphedema is 4.49 and 16.74 for functional limitation. The ‘t’ table value is 2.878 at 
0.005 level of significance. Since the calculated Unpaired ‘t’ value is more than ‘t’ 
table value, there is significant difference in lymphedema and functional limitation 
among Group A and Group B. Thus there is significant difference between Group A 
and Group B in reducing lymphedema and functional limitation for post radical 
mastectomy subjects. So we accept Alternate hypothesis HA1 and HA2 and reject Null 
hypothesis H01 and H02. 
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V. CONCLUSION 
5.1  Conclusion 
 A Pre-test, Post-test Experimental study was conducted to compare the effect 
of lymphatic manipulation and pneumatic compression pump in improving 
lymphedema for post radical mastectomy. 
30 subjects with lymphedema in post radical mastectomy were included in this 
study by Consecutive sampling and randomly assigned to two groups as Group A and 
Group B consisting of 15 subjects each. Group A was treated with lymphatic 
manipulation and Group B was treated with intermittent pneumatic compression 
pump. Lymphedema were assessed before and after the intervention by tonometry and 
functioning limitation by questionnaire. 
When comparing the lymphedema and functional limitation, mean values of 
Group A and Group B. Group A subjects who received lymphatic manipulation 
showed more difference than Group B who received intermittent pneumatic 
compression pump. 
Hence it is concluded that lymphatic manipulation is more effective than 
intermittent pneumatic compression pump in reducing lymphedema and functional 
limitation in post radical mastectomy subjects. 
5.2 Limitations 
The study was conducted with a sample size of 30, the age group of the 
sample being 40 to 55 years with treatment duration of 12 weeks thrice a week. 
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5.3 Recommendations 
Future research can be conducted with a bigger sample size, wider age group, 
different variables, more consistent outcome measures and different treatment 
durations. 
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VII ANNEXURE  
A.I. Annexure:  
ASSESSMENT CHART 
Physical Therapy Assessment Chart 
Name   : 
Age   :  
Gender  : 
Occupation  : 
Chief complaints : 
Medical history 
• Past  : 
• Present : 
Family history  : 
Social history  : 
Associated problems :  
On observation 
• Body Built  :  
• Posture  : 
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• Attitude of limbs : 
• Muscle wasting :  
• Edema   :  
• Involuntary movement :  
• Gait   :  
• Deformity  :  
On palpation 
• Tenderness  : 
• Swelling  : 
• Muscle tightness : 
• Warmth  : 
• Other if any  : 
Pain assessment 
• Side    : 
• Site    : 
• Duration  : 
• Nature   : 
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• Aggravating factor : 
• Relieving factor  : 
• Other if any  : 
On examination 
• Vital signs   : 
• Motor Assessment  : 
o Range Of Motion : 
o End Feels  : 
o Manual Muscle Testing: 
o Joint Positions  :  
• Sensory Assessment  
o Superficial Sensations : 
o Deep Sensations : 
o Combined  : 
• Reflexes 
o Superficial  : 
o Deep   : 
o Clonuses  : 
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• Dermatomes and Myotomes : 
• Limb Length Discrepancies : 
• Special Tests   : 
• Functional Assessments : 
• Gait Assessments  : 
Investigations  : 
 
Clinical Impression  : 
 
Differential Diagnosis : 
 
Final Diagnosis  : 
 
 
Goals    
• Short Term Goals : 
• Long Term Goals : 
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Treatment Plan  
• Intermittent pneumatic compression pump : 
• Lymphatic Manipulations   : 
Home Assessments  : 
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A.II. Annexure:  
Lymphedema Functioning, Disability and Health Questionnaire 
In Sections A, B and C questions are asked in the following format. Please mark your 
answers by putting an “X” in one of the boxes. 
Serial 
No.  Question  None Mild
Mode
rate
Seve
re
Extre
me 
Not 
Applicable / 
Remarks
   Scores  0 1 2 3 4    
Physical 
1  Heavy       
2  Stiff       
3  Swollen                   
4  Lost Strength                   
5  Tingle                   
6  Hurt                   
7  Tensed Skin                   
Mental 
8  Feel Sad                   
9  Feel Discouraged                   
10  Lack of Self Confidence                   
11  Feel Stressed                   
 Household Activity 
12  Clean                   
13  Cook                   
14  Iron                   
15  Garden                   
Mobility 
16  Lift Heavy objects                   
17  Sleep on affected side                   
18  Work on computer                   
19  bathe                   
20  Drive                    
21  Walk more than 2 Km                   
22  Cycle                   
23 
Task with elevated 
arms       
Social Life 
24  Go for picnic       
25  Perform Hobbies       
26  Practice Sports                   
27  Wear Cloths of choice                   
28  Do a job                   
29  Do Social activities                   
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A.III. Annexure:  
Raw Scores  
A.3.1 Calculation for Pre and post-test values of lymphedema using tonometry 
among Group A. 
Serial No. Pre treatment post treatment ࢞ 1 ࢞૚ି ࢞ഥ૚ ሺ࢞૚ି  ࢞ഥ૚ሻ૛ ࢞ 1
2 
1 43 38 5 2 4.00 25 
2 42 40 2 -1 1.00 4 
3 45 41 4 1 1.00 16 
4 46 41 5 2 4.00 25 
5 40 38 2 -1 1.00 4 
6 41 39 2 -1 1.00 4 
7 45 42 3 0 0.00 9 
8 44 41 3 0 0.00 9 
9 38 36 2 -1 1.00 4 
10 39 37 2 -1 1.00 4 
11 44 38 6 3 9.00 36 
12 42 37 5 2 4.00 25 
13 43 41 2 -1 1.00 4 
14 41 40 1 -2 4.00 1 
15 38 37 1 -2 4.00 1 
∑ 631 586 45 0 36.00 171 
    ࢞ഥ૚= 3       
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A.3.2 Calculation for Pre and post-test values of lymphedema using tonometry 
among Group B. 
Serial No. 
Pre 
treatment post treatment ࢞2 ࢞૛ି ࢞ഥ૛ ሺ࢞૛ି  ࢞ഥ૛ሻ૛ ࢞ 2
2 
1 43 42 1 -0.06 0.00 1 
2 42 41 1 -0.06 0.00 1 
3 45 44 1 -0.06 0.00 1 
4 46 45 1 -0.06 0.00 1 
5 40 39 1 -0.06 0.00 1 
6 41 39 2 0.94 0.88 4 
7 45 44 1 -0.06 0.00 1 
8 44 43 1 -0.06 0.00 1 
9 38 38 0 -1.06 1.12 0 
10 39 38 1 -0.06 0.00 1 
11 44 43 1 -0.06 0.00 1 
12 42 41 1 -0.06 0.00 1 
13 43 42 1 -0.06 0.00 1 
14 41 39 2 0.94 0.88 4 
15 38 37 1 -0.06 0.00 1 
∑ 631 615 16 0.1 2.934 20 
    ࢞ഥ૛= 1.066667       
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A.3.3. Calculation for Pre and post-test values of functional limitation in Group 
A using Lymphedema Functioning, Disability and Health Questionnaire. 
 
Serial No. 
Pre 
treatment post treatment ࢞ 1 ࢞૚ି ࢞ഥ૚ ሺ࢞૚ି  ࢞ഥ૚ሻ૛ ࢞ 1
2 
1 76 57 19 0.47 0.22 361 
2 77 63 14 -4.53 20.55 196 
3 88 71 17 -1.53 2.35 289 
4 80 62 18 -0.53 0.28 324 
5 95 78 17 -1.53 2.35 289 
6 78 60 18 -0.53 0.28 324 
7 98 83 15 -3.53 12.48 225 
8 73 52 21 2.47 6.08 441 
9 92 70 22 3.47 12.02 484 
10 72 56 16 -2.53 6.42 256 
11 82 61 21 2.47 6.08 441 
12 84 67 17 -1.53 2.35 289 
13 86 65 21 2.47 6.08 441 
14 80 56 24 5.47 29.88 576 
15 94 76 18 -0.53 0.28 324 
∑ 1255 977 278 0.00 107.73 5260 
    ࢞ഥ૚= 18.53333       
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A.3.4 Calculation for Pre and post-test values of functional limitation in Group B 
using lymphedema Functioning, Disability and Health Questionnaire. 
 
Serial No. 
Pre 
treatment post treatment ࢞2 ࢞૛ି ࢞ഥ૛ ሺ࢞૛ି  ࢞ഥ૛ሻ૛ ࢞ 2
2 
1 76 71 5 -0.40 0.16 25 
2 77 72 5 -0.40 0.16 25 
3 88 80 8 2.60 6.76 64 
4 80 74 6 0.60 0.36 36 
5 95 89 6 0.60 0.36 36 
6 78 74 4 -1.40 1.96 16 
7 98 91 7 1.60 2.56 49 
8 73 69 4 -1.40 1.96 16 
9 92 86 6 0.60 0.36 36 
10 72 67 5 -0.40 0.16 25 
11 82 75 7 1.60 2.56 49 
12 84 80 4 -1.40 1.96 16 
13 86 81 5 -0.40 0.16 25 
14 80 76 4 -1.40 1.96 16 
15 94 89 5 -0.40 0.16 25 
∑ 1255 1174 81 81.00 21.6 459 
    ࢞ഥ૛= 5.4       
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A.IV.Annexure:  
Gallery 
                                
Tonometer 
 
 
Intermittent pneumatic pump 
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Assessment with Tonometer 
 
Intermittent pneumatic compression pump 
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Lymphatic manipulation rotary technique  
 
 
 
Lymphatic manipulation pump technique  
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Lymphatic manipulation scoop technique  
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A.V. Annexure:  
 
PATIENT CONSENT FORM 
 
 
I ……………………………………………………aged……yrs, voluntarily 
consent to participate in the research named  “A COMPARATIVE STUDY OF 
LYMPHATIC MANIPULATION VERSUS INTERMITTENT PNEUMATIC 
COMPRESSION PUMP TO REDUCE LYMPHEDEMA AND ITS RELATED 
FUNCTIONAL LIMITATION IN POST RADICAL  MASTECTOMY” 
 
The researcher has explained me the treatment approach in brief, risk of 
participation and has answered all the questions pertaining to the study to my 
satisfaction. 
 
 
 
Signature of Subject       Signature of Researcher  
 
 
 
Signature of Witness 
 
